SmallCap
CompaniesMapStatistics

(주)엘앤씨바이오

Listed
Venture Certified
Data Quality: 95/10

Basic Information


Listed

Stock Code: 290650

Company Name(주)엘앤씨바이오
English NameL&C BIO Co., Ltd
Business Reg. No.1298664008
CEO이환철, 이재호 (각자 대표이사)
Address경기도 성남시 중원구 둔촌대로 474, 605호, 606호, 607호 (선텍시티)
Industry그 외 기타 의료용품 및 의약 관련제품 제조업
Industry Code212
Established2011-08-02
Phone031-776-2975
Websitewww.lncbio.co.kr
Regular Employees11persons
Corp. Reg. No.1311110288992

Investment Metrics


Market Cap
-
Op. Margin
2.99%
ROE
-9.15%
Debt Ratio
125.04%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2012-05-17 ~ 2014-05-16201201045332012-05-17
기술평가보증기업(기금)2014-05-17 ~ 2016-05-16201401074452012-05-17
기술평가보증기업(기금)2016-05-17 ~ 2018-05-16201601073852012-05-17
기술평가보증기업(기금)2018-05-17 ~ 2020-05-16201801062842012-05-17
기술평가보증기업(기금)2020-05-17 ~ 2022-05-16202001053292012-05-17
혁신성장유형2022-05-17 ~ 2025-05-16202205040300362012-05-17
혁신성장유형2025-05-17 ~ 2028-05-16202505200300492012-05-17

Financial Statements


3-Year Financial Data

Revenue CAGR +16.0%

Item202420232022
Revenue

562B

561B

417B

Operating Profit

17B

80B

67B

Net Profit

-115B

631B

41B

Total Assets

2,832B

2,238B

1,592B

Total Liabilities

1,573B

886B

713B

Total Equity

1,258B

1,352B

879B

Risk Indicators


1 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
562B

14.8%

vs. 3-Year Avg.: 489B
Operating Profit
17B

77.0%

vs. 3-Year Avg.: 73B
Op. Margin
3.0%

80.2%

vs. 3-Year Avg.: 15.1%
Debt Ratio
125.0%

70.6%

vs. 3-Year Avg.: 73.3%
ROE
-9.1%

135.7%

vs. 3-Year Avg.: 25.6%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
이환철, 이재호 (각자 대표이사)대표이사대표

Employment Status


NPS Subscribers

11persons

CEO이환철, 이재호 (각자 대표이사)
Est. Avg. Annual Salary

4,66210K

(38810K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+0persons

Left (12 mo)

-0persons

Net Change (12 mo)

0persons

NPS Join Date

2007-02-01

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

35 Patents
25 Registered
3 in 3 Years
A61 의학/수의학/위생 (89)
B33 처리조작/운수 (6)
C12 생화학/미생물학 (5)
A01 농업/임업/축산 (5)
C07 유기화학 (4)
Patent TitleApplicantApplication No.Filing DateStatus
인체 유래 조직을 포함하는 규칙성 치밀결합조직 치료용 조성물주식회사 엘앤씨바이오10202500605042025-05-09공개
무세포 동종진피를 포함하는 치주조직 재생유도재 및 그 제조 방법주식회사 엘앤씨바이오10202401987722024-12-27등록
3D 프린팅 기술을 이용한 골 스캐폴드 및 그 제조방법주식회사 엘앤씨바이오10202301503302023-11-02등록
인체 이식을 위한 3D 프린팅 구조체 및 그 제조방법주식회사 엘앤씨바이오10202101679682021-11-30거절
동물 피부 유래의 초미세 무세포 진피 제조 방법주식회사 엘앤씨바이오10202101538632021-11-10등록

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status

Updated: 2026-03-05

Venture

Other Public Data


2 Additional Data Sources

{
  "address": "경기도 성남시",
  "ceo_name": "이환철",
  "certificate": [
    {
      "cert_number": "20120104533",
      "changes": "",
      "disclosure_date": "2012-05-17",
      "first_cert_date": "2012-05-17",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-05-17 ~ 2014-05-16"
    },
    {
      "cert_number": "20140107445",
      "changes": "",
      "disclosure_date": "2014-06-23",
      "first_cert_date": "2012-05-17",
      "no": "2",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-05-17 ~ 2016-05-16"
    },
    {
      "cert_number": "20160107385",
      "changes": "",
      "disclosure_date": "2016-06-17",
      "first_cert_date": "2012-05-17",
      "no": "3",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-05-17 ~ 2018-05-16"
    },
    {
      "cert_number": "20180106284",
      "changes": "",
      "disclosure_date": "2018-05-25",
      "first_cert_date": "2012-05-17",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-05-17 ~ 2020-05-16"
    },
    {
      "cert_number": "20200105329",
      "changes": "",
      "disclosure_date": "2020-04-27",
      "first_cert_date": "2012-05-17",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2020-05-17 ~ 2022-05-16"
    },
    {
      "cert_number": "20220504030036",
      "changes": "",
      "disclosure_date": "2022-05-04",
      "first_cert_date": "2012-05-17",
      "no": "6",
      "type": "혁신성장유형",
      "valid_period": "2022-05-17 ~ 2025-05-16"
    },
    {
      "cert_number": "20250520030049",
      "changes": "",
      "disclosure_date": "2025-05-20",
      "first_cert_date": "2012-05-17",
      "no": "7",
      "type": "혁신성장유형",
      "valid_period": "2025-05-17 ~ 2028-05-16"
    }
  ],
  "company_name": "주식회사 엘앤씨바이오",
  "financials": {
    "2022": {
      "capital_stock": 11388444000,
      "cost_of_sales": 18989131000,
      "current_assets": 57879101000,
      "current_liabilities": 16021705000,
      "gross_profit": 22753795000,
      "net_income": 4093377000,
      "net_income_bs": 4135811000,
      "non_current_assets": 101291996000,
      "non_current_liabilities": 55252267000,
      "non_operating_expenses": 4805368000,
      "non_operating_income": 2197320000,
      "operating_profit": 6701425000,
      "revenue": 41742926000,
      "sga_expenses": 16052370000,
      "total_assets": 159171097000,
      "total_equity": 87897125000,
      "total_liabilities": 71273972000
    },
    "2023": {
      "capital_stock": 11388444000,
      "cost_of_sales": 25449753000,
      "current_assets": 124464758000,
      "current_liabilities": 85639318000,
      "gross_profit": 30681800000,
      "net_income": 63051145000,
      "net_income_bs": 48880853000,
      "non_current_assets": 99286419000,
      "non_current_liabilities": 2923507000,
      "non_operating_expenses": 10371109000,
      "non_operating_income": 65467133000,
      "operating_profit": 7955121000,
      "revenue": 56131553000,
      "sga_expenses": 22726678000,
      "total_assets": 223751178000,
      "total_equity": 135188353000,
      "total_liabilities": 88562825000
    },
    "2024": {
      "capital_stock": 11388444000,
      "cost_of_sales": 27858534000,
      "current_assets": 121716660000,
      "current_liabilities": 140418055000,
      "gross_profit": 28310330000,
      "net_income": -11511352000,
      "net_income_bs": -7078467000,
      "non_current_assets": 161445173000,
      "non_current_liabilities": 16918668000,
      "non_operating_expenses": 18630080000,
      "non_operating_income": 5436486000,
      "operating_profit": 1682242000,
      "revenue": 56168864000,
      "sga_expenses": 26628088000,
      "total_assets": 283161833000,
      "total_equity": 125825110000,
      "total_liabilities": 157336723000
    }
  },
  "industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
  "investment": [],
  "phone": "02-541-****",
  "source": "pg_migration"
}

{
  "address": "서울특별시 서초구 강남대로",
  "brno": "214880****",
  "cappedWarning": false,
  "companyName": "(주)엘앤씨바이오",
  "estimatedAvgAnnualSalary": 46619940,
  "estimatedAvgMonthlySalary": 3884995,
  "fetchedAt": "2026-03-05T18:16:57.858Z",
  "industryCode": "515080",
  "industryName": "의료 기기 도매업",
  "joinDate": "20070201",
  "last12MonthsHired": 0,
  "last12MonthsLeft": 0,
  "last12MonthsNetChange": 0,
  "leaveDate": null,
  "monthlyPensionAmount": 4059820,
  "monthlyTrend": [
    {
      "lostSubscribers": 0,
      "newSubscribers": 0,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6369263",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 11,
  "turnoverMonths": 1
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
Venture System Detail2026-03-05
Collected
nps2026-03-05
Collected
SME Status Info2026-03-05
Collected
DART Financial2026-02-26
Collected
Employment Insurance2026-02-25
Collected
G2B Procurement2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected